Bots, editor, reviewer, Administrators
13,951
edits
Feed:Trial Acronyms: Difference between revisions
Jump to navigation
Jump to search
no edit summary
No edit summary |
No edit summary |
||
| Line 89: | Line 89: | ||
"ESSENCE" : "Efficacy and Safety of Subcutaneous Enoxaparin in Non–Q-Wave Coronary Events Study Group", | "ESSENCE" : "Efficacy and Safety of Subcutaneous Enoxaparin in Non–Q-Wave Coronary Events Study Group", | ||
"CRASH-2" : "Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage 2", | "CRASH-2" : "Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage 2", | ||
"3C" : "Cough Complication Cohort", | |||
"CHOICE" : "CHOICE is not an abbreviation per a communication with the research team", | "CHOICE" : "CHOICE is not an abbreviation per a communication with the research team", | ||
"SELECT-D" : "Anticoagulation Therapy in Selected Cancer Patients at Risk of Recurrence of Venous Thromboembolism", | "SELECT-D" : "Anticoagulation Therapy in Selected Cancer Patients at Risk of Recurrence of Venous Thromboembolism", | ||